TrialAsian Pacific journal of cancer prevention : APJCP2018

A Phase IV Efficacy Study of Formeta Plus Carboplatin as First-Line Treatment of Advanced Non-Squamous, Non-Small Cell Lung Cancer in Iran: An Affordable Price with Clinical Benefit

Adnan Khosravi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.